Ma Q - Search Results

1

Molecular and pharmacologic profile of tinzaparin and a comparable low-molecular-weight bacterial sulfaminoheparosan.

Maddineni J, Ma Q, Hoppensteadt DA, Demir M, Manoni M, Cornelli U, Fareed J. Maddineni J, et al. Among authors: ma q. Clin Appl Thromb Hemost. 2004 Jan;10(1):27-37. doi: 10.1177/107602960401000105. Clin Appl Thromb Hemost. 2004. PMID: 14979402 Free article.

2

Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3.

Ma Q, Dudas B, Daud A, Iqbal O, Hoppensteadt D, Jeske W, Cornelli U, Lee J, Lorens S, Mervis R, Hanin I, Capila I, Linhardt R, Fareed J. Ma Q, et al. Thromb Res. 2002 Feb 15;105(4):303-9. doi: 10.1016/s0049-3848(01)00413-3. Thromb Res. 2002. PMID: 12031824

3

Reference intervals of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisited.

Gerbutavicius R, Fareed J, Messmore HL Jr, Iqbal O, Hoppensteadt DA, Wehrmacher WH, Demir M, Piccolo P, Ahmad S, Ma Q, Griniute R. Gerbutavicius R, et al. Among authors: ma q. Clin Appl Thromb Hemost. 2002 Apr;8(2):115-24. doi: 10.1177/107602960200800206. Clin Appl Thromb Hemost. 2002. PMID: 12121051 Free article.

4

Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional use.

Tobu M, Iqbal O, Ma Q, Schultz C, Jeske W, Hoppensteadt D, Lewis B, Fareed D, Fareed J. Tobu M, et al. Among authors: ma q. Clin Appl Thromb Hemost. 2003 Jan;9(1):1-17. doi: 10.1177/107602960300900101. Clin Appl Thromb Hemost. 2003. PMID: 12643318 Free article.

5

Biochemical and pharmacologic heterogeneity in low molecular weight heparins. Impact on the therapeutic profile.

Fareed J, Hoppensteadt D, Schultz C, Ma Q, Kujawski MF, Neville B, Messmore H. Fareed J, et al. Among authors: ma q. Curr Pharm Des. 2004;10(9):983-99. doi: 10.2174/1381612043452811. Curr Pharm Des. 2004. PMID: 15078128 Review.

6

Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosis.

Fareed J, Ma Q, Florian M, Maddineni J, Iqbal O, Hoppensteadt DA, Bick RL. Fareed J, et al. Among authors: ma q. Semin Thromb Hemost. 2004 Feb;30 Suppl 1:89-104. doi: 10.1055/s-2004-823007. Semin Thromb Hemost. 2004. PMID: 15085470 Review.

7

Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides.

Ma Q, Tobu M, Schultz C, Jeske W, Hoppensteadt D, Walenga J, Cornelli U, Lee J, Linhardt R, Hanin I, Fareed J. Ma Q, et al. Thromb Res. 2007;119(5):653-61. doi: 10.1016/j.thromres.2006.05.007. Epub 2006 Jul 7. Thromb Res. 2007. PMID: 16824584 Free PMC article.

8

Global anticoagulant effects of a novel sulfated pentomanan oligosaccharide mixture.

Piccolo P, Iqbal O, Demir M, Ma Q, Gerbutavicius R, Fareed J. Piccolo P, et al. Among authors: ma q. Clin Appl Thromb Hemost. 2001 Apr;7(2):149-52. doi: 10.1177/107602960100700212. Clin Appl Thromb Hemost. 2001. PMID: 11292193 Free article.

9

Influence of different anticoagulant agents on fibrinopeptide a generation.

Tobu M, Iqbal O, Messmore HL, Ma Q, Hoppensteadt DA, Fareed J. Tobu M, et al. Among authors: ma q. Clin Appl Thromb Hemost. 2003 Oct;9(4):273-92. doi: 10.1177/107602960300900403. Clin Appl Thromb Hemost. 2003. PMID: 14653437 Free article.

10

Comparative tissue factor pathway inhibitor release potential of heparins.

Tobu M, Ma Q, Iqbal O, Schultz C, Jeske W, Hoppensteadt DA, Fareed J. Tobu M, et al. Among authors: ma q. Clin Appl Thromb Hemost. 2005 Jan;11(1):37-47. doi: 10.1177/107602960501100104. Clin Appl Thromb Hemost. 2005. PMID: 15678271 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,366 results

Search Page

Filters